Clene Inc.

• Clene Inc Estimates – TRADEGATE:84C0
  TradingView · 23 Oct 2026
• Form 4 Clene Inc.: Robert Dee Etherington (Director, President & CEO) For: 20 October
  Investing.com India · 22 Oct 2026
• Clene Submits NDA Seeking Accelerated Approval for ALS Drug
  NeurologyLive · 20 Oct 2026
• Clene seeks FDA accelerated approval of oral ALS treatment
  ALS News Today · 20 Oct 2026
• Clene submits new drug application for ALS treatment CNM-Au8 By Investing.com
  Investing.com India · 19 Oct 2026
• Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALS
  The Manila Times · 19 Oct 2026
• Clene Inc. Submits New Drug Application to Fda for Cnm-Au8 for the Treatment of Als
  www.marketscreener.com · 19 Oct 2026
• An application seeks accelerated approval for Clene’s ALS drug. It was submitted in October.
  Stock Titan · 19 Oct 2026
• Clene (NasdaqCM:CLNN) Stock Forecast & Analyst Predictions
  Simply Wall Street · 19 Oct 2026
• Clene submits FDA application for accelerated a...
  Pluang · 19 Oct 2026
• Clene Inc. (CLNN) Drops 7.88% to $3.39 as Shares Test Lower Support - Entry Point Alerts
  https://www.siam.in/ · 13 Oct 2026
• Clene Targets Q4 FDA Filing for ALS Drug CNM-Au8, Eyes Mid-2027 Decision
  TradingView · 02 Oct 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →